Cardiac and vascular device maker AGA Medical Holdings Inc. (NYSE: AGAM) has been awarded $2.6 million in damages by a German court in a patent-infringement case.
AGA’s patent dispute with Germany-based Occlutech GmbH stretches back to 2006 and involves intravascular occlusion devices and the method of manufacturing those devices, according to a statement from Plymouth, Minn.-based AGA.
AGA won a judgment against Occlutech in 2007, but the German company appealed the decision. The court’s latest decision is subject to appeal from Occlutech, as well.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The court awarded AGA a judgment of 2.1 million euros, which equates to about $2.6 million using current exchange rates. The amount the court awarded was the amount AGA sought, according to the statement.
AGA markets its Amplatzer line of products in 112 countries. Last month, the company enrolled the first patient in a clinical trial of its Amplatzer Cardiac Plug that’s intended to show the device’s safety and efficacy in preventing strokes in patients with abnormal heartbeats.
